The physicians in the Division of Hematology/Oncology at the Children's Hospital of Michigan are involved in extensive clinical, translational and bench research in pediatric blood diseases, coagulation and bleeding disorders and cancer/leukemia. Much of this research is funded by the National Institutes of Health, National Cancer Institute and other agencies, including the Leukemia and Lymphoma Society and the National Hemophilia Foundation.

Members of the division have held many leadership positions with national programs – including the Children’s Oncology Group, Medical Director of the National Hemophilia Foundation and Chair of the International Society of Thrombosis and Hemostasis Scientific Committee. They have served on editorial boards, publish journal articles and are frequent lecturers at national and international meetings.

Click below for recent groundbreaking research at the Children's Hospital of Michigan.

Pediatric Researchers Find Evidence that Help Prevent Abnormalities in Heart Muscle after Children Receive Chemotherapy

Children’s Hospital of Michigan DMC Research Team Leads Cardiology Component of Clinical Trial to Protect the Hearts of Children Who Receive Chemotherapy

Detroit Researchers Help Identify a Key Gene Mutation That Can Trigger ALL

Multi-Center Pediatric Research Study Targets Cancer with TCells